![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Immunol. , 13 April 2022
Sec. Cancer Immunity and Immunotherapy
Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.859331
A retraction of this article was approved in:
Retraction: CCDC88A post-transcriptionally regulates VEGF via miR-101 and subsequently regulates hepatocellular carcinoma
Citation: Hu Q, Li Y, Chen H, Liao H, He Y and Zheng Q (2022) CCDC88A Post-Transcriptionally Regulates VEGF via miR-101 and Subsequently Regulates Hepatocellular Carcinoma. Front. Immunol. 13:859331. doi: 10.3389/fimmu.2022.859331
Received: 04 February 2022; Accepted: 14 March 2022;
Published: 13 April 2022; Retracted: 25 September 2024.
Edited by:
Saravanan Sekaran, Saveetha Dental College and Hospitals, IndiaReviewed by:
Ananth Kumar Kammala, University of Texas Medical Branch at Galveston, United StatesDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.